Physician profile
Shane L Martin
NPI 1659351682
$243,774.68
in general payments reported to CMS, 2019-2025
15 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92K · 2020: $50K · 2021: $27K · 2022: $51K · 2023: $11K · 2024: $12K · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $3,956 · Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,750.00 |
| Travel and Lodging | $3,955.72 |
| Food and Beverage | $927.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $223,821.26 | 2019-2025 | Mako, Triathlon |
| Smith+Nephew, INC. | $18,304.01 | 2020-2025 | Real Intelligence, Allevyn Heel 10.5cm X 13.5cm Ctn 5, Pico 7 |
| Zimmer Biomet Holdings, INC. | $442.77 | 2020-2022 | |
| Lima USA, INC. | $357.14 | 2020 | |
| Depuy Synthes Sales INC. | $234.21 | 2019-2022 | |
| Arthrosurface Incorporated | $200.57 | 2020 | |
| Total Joint Orthopedics, INC. | $182.16 | 2024 | |
| Flower Orthopedics Coporation | $66.37 | 2025 | |
| Think Surgical, INC. | $52.61 | 2024 | |
| Linvatec Corporation | $25.21 | 2019 | |
| Boston Scientific Corporation | $22.55 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.41 | 2025 | |
| Medtronic USA, INC. | $16.91 | 2020 | |
| Ethicon US, LLC | $15.23 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.